Praxis Precision Medicines
Clinical trials sponsored by Praxis Precision Medicines, explained in plain language.
-
New hope for kids with rare epilepsy: drug trial targets seizures
Disease control OngoingThis study tests an experimental drug called PRAX-562 in 77 children with rare genetic epilepsies (SCN2A or SCN8A) that cause severe seizures starting in infancy. The goal is to see if the drug is safe and can reduce monthly motor seizures. The trial has a double-blind phase foll…
Phase: PHASE2, PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated May 17, 2026 16:10 UTC
-
Epilepsy drug vormatrigine moves to Long-Term safety check in 700 patients
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety of the drug vormatrigine in adults with epilepsy who have already taken it in earlier studies. About 700 people will take the drug and be monitored for side effects like changes in temperature, heart rate, and blood pressure. The goal is to s…
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated May 17, 2026 16:06 UTC
-
New pill could steady shaky hands in common movement disorder
Symptom relief ENROLLING_BY_INVITATIONThis study tests an experimental drug called ulixacaltamide against a placebo in 1000 adults with essential tremor, a condition that causes shaking hands. The goal is to see if the drug safely reduces how much tremors interfere with daily activities like eating or writing. Partic…
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Symptom relief
Last updated May 17, 2026 16:12 UTC